Giulia C. Kennedy, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 30,714 shares at $35.37 ($1.2M) on 2021-12-06, disclosed to the SEC on 2021-12-08.
Open-market sale of $1.2M VCYT by Chief Scientific & Med Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.37 | 3,550 | $126K | 10.8% |
| 2 | $35.37 | 3,550 | $126K | 10.8% |
| 3 | $36.11 | 3,897 | $141K | 12.1% |
| 4 | $36.11 | 3,897 | $141K | 12.1% |
| 5 | $37.26 | 1,785 | $67K | 5.7% |
| 6 | $37.26 | 1,785 |
| $67K |
| 5.7% |
| 7 | $39.69 | 4,375 | $174K | 15.0% |
| 8 | $39.69 | 4,375 | $174K | 15.0% |
| 9 | $41.55 | 1,750 | $73K | 6.3% |
| 10 | $41.55 | 1,750 | $73K | 6.3% |
| Total | $37.71 avg | 30,714 | $1.2M | 100% |
| Filing → |
| VCYT | SELL | 2022-11-08 | $26K | — | Filing → |
| VCYT | SELL | 2022-08-09 | $27K | — | Filing → |
| VCYT | SELL | 2022-03-09 | $1.0M | — | Filing → |